News
Moderna is seeking emergency use authorization from the FDA for its Covid-19 vaccine for children 6 months through 5 years of age.
The company expects to make the updated Spikevax available to U.S. patients in time for the 2025-26 respiratory virus season.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results